C
MXCT icon

Covestor’s MaxCyte MXCT Stock Holding History

Covestor’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5
Closed – – 2576
2025
Q2 		$0 Hold
5
– – ﹤0.01% 2542
2025
Q1 		$0 Hold
5
– – ﹤0.01% 2540
2024
Q4 		$0 Buy
5
+4
+400% +$15 ﹤0.01% 2551
2024
Q3 		$0 Sell
1
-1
-50% -$4 ﹤0.01% 2543
2024
Q2 		$0 Sell
2
-38
-95% -$163 ﹤0.01% 2556
2024
Q1 		$0 Buy
40
+20
+100% +$94 ﹤0.01% 2553
2023
Q4 		$0 Buy
20
+1
+5% +$4 ﹤0.01% 2494
2023
Q3 		$0 Sell
19
-7
-27% -$28 ﹤0.01% 2478
2023
Q2 		$0 Buy
26
+10
+63% +$46 ﹤0.01% 2458
2023
Q1 		$0 Sell
16
-7
-30% -$34 ﹤0.01% 2378
2022
Q4 		$0 Buy
+23
New +$141 ﹤0.01% 2399

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Covestor's MXCT Position: Q3 2025 in Review

Covestor sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 5 shares.

Covestor first reported a position in MXCT in Q4 2022 and held it in 11 quarters. The position peaked at $0 in Q2 2025. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Covestor reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
  • Covestor sold 5 MaxCyte shares in Q3 2025.
  • Covestor first reported a position in MaxCyte in Q4 2022 and held it in 11 quarters.
  • Covestor's MaxCyte position peaked at $0 in Q2 2025.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Covestor's 13F filing for Q3 2025, filed 30 Oct 2025.